Published in Eur J Cell Biol on April 01, 1991
Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer (2002) 2.38
RhoA is required for cortical retraction and rigidity during mitotic cell rounding. J Cell Biol (2003) 2.34
Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog (2009) 2.29
The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. J Clin Invest (1995) 1.51
Involvement of the GTP binding protein Rho in constitutive endocytosis in Xenopus laevis oocytes. J Cell Biol (1995) 1.36
Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT). Proc Natl Acad Sci U S A (2011) 1.31
C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins. Naunyn Schmiedebergs Arch Pharmacol (2006) 1.11
Cytotoxicity and ADP-ribosylating activity of the mosquitocidal toxin from Bacillus sphaericus SSII-1: possible roles of the 27- and 70-kilodalton peptides. J Bacteriol (1993) 1.03
Isolation and characterization of a Clostridium botulinum C2 toxin-resistant cell line: evidence for possible involvement of the cellular C2II receptor in growth regulation. Infect Immun (1995) 0.97
ADP-ribosylation of the GTP-binding protein Rho by Clostridium limosum exoenzyme affects basal, but not N-formyl-peptide-stimulated, actin polymerization in human myeloid leukaemic (HL60) cells. Biochem J (1994) 0.96
The C terminus of component C2II of Clostridium botulinum C2 toxin is essential for receptor binding. Infect Immun (2000) 0.95
Targeting of the actin cytoskeleton by insecticidal toxins from Photorhabdus luminescens. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.93
ADP-ribosylation of Rho proteins by Clostridium botulinum exoenzyme C3 is influenced by phosphorylation of Rho-associated factors. Biochem J (1994) 0.90
Binding and internalization of Clostridium botulinum C2 toxin. Infect Immun (2009) 0.89
Tailored ß-cyclodextrin blocks the translocation pores of binary exotoxins from C. botulinum and C. perfringens and protects cells from intoxication. PLoS One (2011) 0.89
Morphological changes of cultured endothelial cells after microinjection of toxins that act on the cytoskeleton. Infect Immun (1992) 0.89
Functional characterization of an extended binding component of the actin-ADP-ribosylating C2 toxin detected in Clostridium botulinum strain (C) 2300. Infect Immun (2010) 0.84
Molecular and biological characterization of Streptococcal SpyA-mediated ADP-ribosylation of intermediate filament protein vimentin. J Biol Chem (2012) 0.83
A recombinant fusion toxin based on enzymatic inactive C3bot1 selectively targets macrophages. PLoS One (2013) 0.81
Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.80
Rho-ROCK and Rac-PAK signaling pathways have opposing effects on the cell-to-cell spread of Marek's Disease Virus. PLoS One (2012) 0.80
Therapeutic effects of Clostridium botulinum C3 exoenzyme. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.80
Vimentin mediates uptake of C3 exoenzyme. PLoS One (2014) 0.79
Tailored cyclodextrin pore blocker protects mammalian cells from clostridium difficile binary toxin CDT. Toxins (Basel) (2014) 0.78
Binding of Clostridium botulinum C3 exoenzyme to intact cells. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.77
EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin. Toxins (Basel) (2016) 0.77
Uptake of clostridium botulinum C3 exoenzyme into intact HT22 and J774A.1 cells. Toxins (Basel) (2015) 0.76
The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals. Toxins (Basel) (2017) 0.75
C3 exoenzyme impairs cell proliferation and apoptosis by altering the activity of transcription factors. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Molecular Evolutionary Constraints that Determine the Avirulence State of Clostridium botulinum C2 Toxin. J Mol Evol (2017) 0.75
Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature (1995) 6.08
Mex67p, a novel factor for nuclear mRNA export, binds to both poly(A)+ RNA and nuclear pores. EMBO J (1997) 5.61
Structure and function of E. coli ribosomes. V. Reconstitution of functionally active 30S ribosomal particles from RNA and proteins. Proc Natl Acad Sci U S A (1968) 5.17
Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol (1990) 4.83
Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J Exp Med (1995) 4.57
Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A (1997) 4.04
Viscoelastic properties of vimentin compared with other filamentous biopolymer networks. J Cell Biol (1991) 3.86
Rho GTPases are over-expressed in human tumors. Int J Cancer (1999) 3.70
Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature (1997) 3.53
Structure and function of ribosomes and their molecular components. Cold Spring Harb Symp Quant Biol (1969) 3.34
The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem (2000) 3.33
Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res (1993) 3.26
Botulinum C2 toxin ADP-ribosylates actin. Nature (1986) 3.16
The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem (1995) 3.02
A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol (1994) 3.02
Hybrid 30S ribosomal particles reconstituted from components of different bacterial origins. Nature (1968) 3.00
Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol (2001) 2.96
CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol (1999) 2.84
Cyclin D1 protein expression and function in human breast cancer. Int J Cancer (1994) 2.81
The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem (1999) 2.78
Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci U S A (2001) 2.67
Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology (2000) 2.66
Structure and function of Escherichia coli ribosomes. VI. Mechanism of assembly of 30 s ribosomes studied in vitro. J Mol Biol (1969) 2.64
GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol Microbiol (2000) 2.56
Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol (1984) 2.51
The Tim core complex defines the number of mitochondrial translocation contact sites and can hold arrested preproteins in the absence of matrix Hsp70-Tim44. EMBO J (1997) 2.28
Mitochondrial protein import: biochemical and genetic evidence for interaction of matrix hsp70 and the inner membrane protein MIM44. J Cell Biol (1994) 2.28
Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun (1999) 2.26
Lysosomal (vacuolar) proteinases of yeast are essential catalysts for protein degradation, differentiation, and cell survival. J Biol Chem (1989) 2.25
The rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. Biochem Biophys Res Commun (1989) 2.23
E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene (1998) 2.12
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol (1994) 2.11
Clostridium difficile toxin B acts on the GTP-binding protein Rho. J Biol Chem (1994) 2.09
The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J (2000) 2.08
A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins. J Biol Chem (1998) 2.08
In vivo biosynthesis of the vacuolar proteinases A and B in the yeast Saccharomyces cerevisiae. J Biol Chem (1982) 1.98
Maturation of nuclear lamin A involves a specific carboxy-terminal trimming, which removes the polyisoprenylation site from the precursor; implications for the structure of the nuclear lamina. FEBS Lett (1989) 1.97
Sec8p and Sec15p are components of a plasma membrane-associated 19.5S particle that may function downstream of Sec4p to control exocytosis. J Cell Biol (1992) 1.96
Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J Cell Biol (2000) 1.94
Nup116p and nup100p are interchangeable through a conserved motif which constitutes a docking site for the mRNA transport factor gle2p. EMBO J (1998) 1.91
Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA. J Virol (1980) 1.90
A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum Mol Genet (2000) 1.87
Sec2 protein contains a coiled-coil domain essential for vesicular transport and a dispensable carboxy terminal domain. J Cell Biol (1990) 1.86
Streptomycin resistance mutation in Escherichia coli: altered ribosomal protein. Science (1968) 1.85
Clostridium perfringens iota toxin ADP-ribosylates skeletal muscle actin in Arg-177. FEBS Lett (1987) 1.85
Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J Biol Chem (1997) 1.83
The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins. Mol Microbiol (1999) 1.81
Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect Immun (2000) 1.78
Antibodies to high molecular weight polypeptides of desmosomes: specific localization of a class of junctional proteins in cells and tissue. Differentiation (1981) 1.77
Maturation of vacuolar (lysosomal) enzymes in yeast: proteinase yscA and proteinase yscB are catalysts of the processing and activation event of carboxypeptidase yscY. EMBO J (1987) 1.76
Structure and function of Escherichia coli ribosomes. I. Partial fractionation of the functionally active ribosomal proteins and reconstitution of artificial subribosomal particles. J Mol Biol (1968) 1.76
Preprotein translocase of the outer mitochondrial membrane: molecular dissection and assembly of the general import pore complex. Mol Cell Biol (1998) 1.71
Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol (2000) 1.70
Loss of occludin and functional tight junctions, but not ZO-1, during neural tube closure--remodeling of the neuroepithelium prior to neurogenesis. Dev Biol (1996) 1.69
Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res (1995) 1.68
Rho GTPases as targets of bacterial protein toxins. Biol Chem (2000) 1.68
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol (2010) 1.67
Juvenile ossifying fibroma. Report of four cases. J Craniomaxillofac Surg (1990) 1.56
Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. Proc Natl Acad Sci U S A (1990) 1.55
The histone genes in HeLa cells are on individual transcriptional units. J Mol Biol (1978) 1.54
Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification. J Biol Chem (2000) 1.54
Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile. Infect Immun (2001) 1.54
Protein import channel of the outer mitochondrial membrane: a highly stable Tom40-Tom22 core structure differentially interacts with preproteins, small tom proteins, and import receptors. Mol Cell Biol (2001) 1.53
Functional staging of ADP/ATP carrier translocation across the outer mitochondrial membrane. J Biol Chem (1999) 1.52
Structure and function of E. coli ribosomes, IV. Isolation and characterization of functionally active ribosomal proteins. Proc Natl Acad Sci U S A (1967) 1.52
Effects of early postfiltration ocular hypotony on visual acuity, long-term intraocular pressure control, and posterior segment morphology. J Glaucoma (2001) 1.51
The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. J Clin Invest (1995) 1.51
Inactivation of Ras by Clostridium sordellii lethal toxin-catalyzed glucosylation. J Biol Chem (1996) 1.50
Low pH-induced formation of ion channels by clostridium difficile toxin B in target cells. J Biol Chem (2001) 1.49
The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity. J Biol Chem (1998) 1.46
Breast reconstruction with latissimus dorsi flap: improved aesthetic results after transection of its humeral insertion. Plast Reconstr Surg (1999) 1.46
Bacterial protein toxins targeting rho GTPases. FEMS Microbiol Lett (2000) 1.46
Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol (1995) 1.45
Involvement of the N-terminal polypeptide of vimentin in the formation of intermediate filaments. J Cell Sci (1983) 1.45
Purification and characterization of an ADP-ribosyltransferase produced by Clostridium limosum. J Biol Chem (1992) 1.45
Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling. Biochemistry (1998) 1.44
Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from botulinum C2 toxin. FEBS Lett (1987) 1.44
The Opitz syndrome gene product, MID1, associates with microtubules. Proc Natl Acad Sci U S A (1999) 1.44
Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol (1997) 1.43
Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med (1993) 1.43
Hematopoietic cells transformed in vitro by REVT avian reticuloendotheliosis virus express characteristics of very immature lymphoid cells. Virology (1981) 1.42
Botulinum ADP-ribosyltransferase C3: a new tool to study low molecular weight GTP-binding proteins. Trends Pharmacol Sci (1989) 1.42
Biogenesis of the yeast lysosome (vacuole): biosynthesis and maturation of proteinase yscB. EMBO J (1988) 1.41
The two segments of the infectious bursal disease virus genome are circularized by a 90,000-Da protein. Virology (1987) 1.41
Requirement of Rac activity for maintenance of capillary endothelial barrier properties. Am J Physiol Heart Circ Physiol (2003) 1.41
Robertsonian chromosomal variation and identification of metacentric chromosomes in feral mice. Chromosoma (1972) 1.41
The N-terminal domain of vimentin alters bladder permeability. J Urol (2003) 1.40
Trisomy-18 syndrome caused by translocation or isochromosome formation. A case report with bibliography. J Med Genet (1972) 1.39
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer (2009) 1.38
Botulinum C2 toxin ADP-ribosylates actin and disorganizes the microfilament network in intact cells. Eur J Cell Biol (1987) 1.37
Endonuclease activity of Escherichia coli DNA helicase I directed against the transfer origin of the F factor. EMBO J (1991) 1.37
Involvement of the GTP binding protein Rho in constitutive endocytosis in Xenopus laevis oocytes. J Cell Biol (1995) 1.36
The genome of infectious bursal disease virus consists of two segments of double-stranded RNA. J Virol (1979) 1.35
Peptide mimics of SNARE transmembrane segments drive membrane fusion depending on their conformational plasticity. J Mol Biol (2001) 1.34